Tripta Sachdev
Physical Medicine and Rehabilitation · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Office
- 1
Offices
1 location · Harmeet S Sachdev MD Inc · 2 clinicians in this group
Looking this up.
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Tripta Sachdev’s office at (405) 358-7314 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A34987 · Current
Licensed to practise in California · since 1980 · expires 2027-08-31 · Punjab University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$38,503
Medicare paid this office $38,503 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Muscle electrical test | 59 | $10,850 | $99 |
| Return visit (30+ min) | 45 | $6,367 | $120 |
| Nerve test | 24 | $5,900 | $246 |
| New patient visit (45+ min) | 27 | $4,161 | $154 |
| Nerve test | 15 | $3,170 | $211 |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 75 · Women 56% · Health risk score 1.23. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Diabetes 39% · Coronary heart disease 34% · Atrial fibrillation 23% · Stroke 23% · Chronic kidney disease 20% · Heart failure 16% · Cancer 16% · COPD 15%.
The office billed $76,140, Medicare allowed $48,697 and paid $38,503; for 271 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 79 | 271 | 75 | 1.23 | $76,140 | $38,503 |
| 2023 | 83 | 257 | 77 | 1.29 | $68,790 | $36,313 |
| 2022 | 95 | 509 | 77 | 1.41 | $84,935 | $45,449 |
| 2021 | 78 | 208 | 78 | 1.51 | $54,110 | $30,917 |
| 2020 | 87 | 217 | 76 | 1.45 | $51,510 | $25,212 |
| 2019 | 195 | 590 | 76 | 1.27 | $152,165 | $74,991 |
| 2018 | 197 | 624 | 75 | 1.22 | $167,445 | $82,395 |
| 2017 | 268 | 761 | 75 | 1.45 | $195,450 | $95,407 |
| 2016 | 258 | 770 | 75 | 1.38 | $191,845 | $97,585 |
| 2015 | 223 | 789 | 75 | 1.28 | $208,450 | $104,643 |
| 2014 | 217 | 775 | 73 | 1.15 | $213,410 | $101,171 |
| 2013 | 212 | 729 | 73 | 1.34 | $188,940 | $92,512 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Muscle electrical test | 53 | $10,682 | $101 |
| Nerve test | 34 | $8,412 | $247 |
| Return visit (30+ min) | 52 | $7,495 | $121 |
| New patient visit (45+ min) | 32 | $4,738 | $148 |
2022: 5 services
| Muscle electrical test | 70 | $13,895 | $104 |
| Nerve test | 40 | $10,177 | $254 |
| Return visit (30+ min) | 54 | $7,412 | $120 |
| New patient visit (45+ min) | 31 | $4,749 | $153 |
| Nerve test | 13 | $2,851 | $219 |
2021: 5 services
| Muscle electrical test | 37 | $7,629 | $107 |
| Nerve test | 23 | $6,147 | $267 |
| Return visit (30+ min) | 45 | $5,844 | $122 |
| New patient visit (45+ min) | 22 | $3,541 | $161 |
| Short return visit (20+ min) | 15 | $1,427 | $89 |
2020: 5 services
| Return visit (30+ min) | 54 | $7,502 | $91 |
| Muscle electrical test | 28 | $5,211 | $93 |
| Nerve test | 19 | $4,701 | $247 |
| New patient visit (45+ min) | 25 | $3,196 | $128 |
| Short return visit (20+ min) | 16 | $1,252 | $70 |
2019: 6 services
| Return visit (30+ min) | 149 | $19,244 | $94 |
| Muscle electrical test | 109 | $18,636 | $90 |
| Nerve test | 63 | $15,561 | $247 |
| Nerve test | 31 | $8,822 | $285 |
| New patient visit (45+ min) | 60 | $8,440 | $141 |
| Nerve test | 13 | $2,402 | $185 |
2018: 7 services
| Muscle electrical test | 125 | $20,258 | $88 |
| Return visit (30+ min) | 136 | $16,228 | $94 |
| Nerve test | 63 | $15,802 | $251 |
| Nerve test | 41 | $11,829 | $289 |
| New patient visit (45+ min) | 81 | $11,633 | $144 |
| Nerve test | 16 | $2,923 | $183 |
| Nerve test | 12 | $2,735 | $228 |
2017: 7 services
| Muscle electrical test | 144 | $23,100 | $87 |
| Return visit (30+ min) | 181 | $21,077 | $90 |
| Nerve test | 71 | $17,235 | $243 |
| New patient visit (45+ min) | 96 | $13,493 | $141 |
| Nerve test | 27 | $7,500 | $278 |
| Nerve test | 28 | $6,435 | $222 |
| Nerve test | 30 | $5,608 | $187 |
2016: 7 services
| Return visit (30+ min) | 201 | $25,756 | $97 |
| Muscle electrical test | 132 | $22,966 | $88 |
| Nerve test | 59 | $14,813 | $247 |
| New patient visit (45+ min) | 72 | $10,499 | $146 |
| Nerve test | 34 | $9,568 | $281 |
| Nerve test | 31 | $6,891 | $222 |
| Nerve test | 20 | $3,690 | $185 |
2015: 8 services
| Nerve test | 121 | $30,335 | $249 |
| Muscle electrical test | 162 | $29,155 | $89 |
| Return visit (30+ min) | 132 | $15,602 | $96 |
| New patient visit (45+ min) | 93 | $13,652 | $147 |
| Nerve test | 25 | $7,021 | $281 |
| Nerve test | 17 | $3,412 | $190 |
| Nerve test | 12 | $2,700 | $225 |
| Short return visit (20+ min) | 14 | $946 | $68 |
2014: 8 services
| Muscle electrical test | 165 | $28,969 | $89 |
| Nerve test | 82 | $20,780 | $253 |
| Return visit (30+ min) | 127 | $14,797 | $99 |
| Nerve test | 57 | $12,957 | $216 |
| New patient visit (45+ min) | 64 | $9,501 | $148 |
| Long return visit (40+ min) | 37 | $4,764 | $122 |
| Nerve test | 25 | $4,316 | $173 |
| Short return visit (20+ min) | 13 | $885 | $68 |
2013: 8 services
| Muscle electrical test | 160 | $25,598 | $83 |
| Nerve test | 77 | $16,572 | $212 |
| New patient visit (45+ min) | 79 | $11,621 | $147 |
| Long return visit (40+ min) | 78 | $11,317 | $127 |
| Return visit (30+ min) | 72 | $7,676 | $98 |
| Nerve test | 41 | $7,274 | $177 |
| Nerve test | 27 | $6,816 | $243 |
| Nerve test | 13 | $3,758 | $289 |
Drugs they prescribed that Part D paid
$1,306
Pharmacies billed $1,306 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 76) in 2024. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
76 generic and 0 brand-name prescriptions · $1,306 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 13 | $682 | $14 |
Year by year
| 2024 | 76 | 22 | 0% (0) | 0% | $1,306 |
| 2023 | 134 | 31 | 0% (0) | 0% | $1,988 |
| 2022 | 143 | 37 | 0% (0) | None | $3,309 |
| 2021 | 156 | 45 | None | None | $3,628 |
| 2020 | 211 | 56 | 5% (11) | None | $4,085 |
| 2019 | 327 | 76 | 3% (11) | 6% | $10,370 |
| 2018 | 284 | 72 | None | 7% | $7,547 |
| 2017 | 253 | 63 | None | 7% | $6,551 |
| 2016 | 277 | 68 | None | 15% | $21,909 |
| 2015 | 290 | 89 | None | 20% | $36,919 |
| 2014 | 242 | 76 | 5% (11) | 13% | $19,499 |
| 2013 | 186 | 59 | 8% (15) | 20% | $17,364 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 77 | $935 | $12 |
| Cyclobenzaprine | 11 | $132 | $12 |
| Duloxetine | 11 | $107 | $10 |
2022: 2 drugs
| Gabapentin | 84 | $1,650 | $20 |
| Duloxetine | 11 | $107 | $10 |
2021: 2 drugs
| Gabapentin | 89 | $2,068 | $23 |
| Duloxetine | 14 | $245 | $17 |
2020: 4 drugs
| Gabapentin | 97 | $1,259 | $13 |
| Duloxetine | 24 | $439 | $18 |
| Pramipexole Dihydrochloride | 17 | $398 | $23 |
| Tramadol | 11 | $16 | $1 |
2019: 7 drugs
| Gabapentin | 154 | $2,109 | $14 |
| Duloxetine | 22 | $472 | $21 |
| Synthroid | 11 | $399 | $36 |
| Cyclobenzaprine | 27 | $255 | $9 |
| Diclofenac | 20 | $181 | $9 |
| Baclofen | 12 | $115 | $10 |
| Tramadol | 11 | $16 | $1 |
2018: 4 drugs
| Gabapentin | 164 | $2,398 | $15 |
| Duloxetine | 17 | $592 | $35 |
| Synthroid | 12 | $426 | $36 |
| Baclofen | 14 | $82 | $6 |
2017: 4 drugs
| Gabapentin | 110 | $1,233 | $11 |
| Synthroid | 13 | $445 | $34 |
| Baclofen | 20 | $135 | $7 |
| Metformin Hcl Er | 11 | $21 | $2 |
2016: 7 drugs
| Gralise | 13 | $6,724 | $517 |
| Gabapentin | 106 | $1,505 | $14 |
| Duloxetine | 11 | $738 | $67 |
| Celecoxib | 13 | $567 | $44 |
| Synthroid | 12 | $408 | $34 |
| Bupropion Hcl Sr | 13 | $223 | $17 |
| Diclofenac | 12 | $120 | $10 |
2015: 5 drugs
| Lidocaine-Prilocaine | 40 | $14,183 | $355 |
| Gralise | 37 | $12,301 | $332 |
| Gabapentin | 103 | $996 | $10 |
| Bupropion Hcl Sr | 11 | $216 | $20 |
| Diclofenac | 20 | $161 | $8 |
2014: 2 drugs
| Lyrica | 14 | $7,619 | $544 |
| Gabapentin | 120 | $1,317 | $11 |
2013: 3 drugs
| Lyrica | 11 | $6,305 | $573 |
| Gabapentin | 68 | $876 | $13 |
| Hydrocodone-Acetaminophen | 15 | $162 | $11 |
Money from drug and device companies
$698 in 2025
| 2025 | 12 | 25 | None | $698 |
| 2024 | 12 | 31 | None | $766 |
| 2023 | 16 | 27 | None | $581 |
| 2022 | 6 | 10 | None | $168 |
| 2021 | 11 | 21 | None | $492 |
| 2020 | 9 | 15 | None | $329 |
| 2019 | 23 | 55 | None | $1,251 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Catalyst Pharmaceuticals | Fycompa | $103 | 4 payments
|
| Abbvie | Botox | $88 | 3 payments
|
| Novartis Pharmaceuticals | Kesimpta | $88 | 3 payments
|
| Neurelis | Valtoco | $79 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $77 | 3 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $57 | 2 payments
|
See all 25 published payments
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Kesimpta | $25 |
| Ucb | Meals · 2025-10-18 | Nayzilam | $30 |
| Catalyst Pharmaceuticals | Meals · 2025-09-23 | Firdapse | $28 |
| Abbvie | Meals · 2025-09-17 | Ubrelvy | $24 |
| Abbvie | Meals · 2025-09-05 | Botox | $32 |
| Genentech USA | Meals · 2025-09-03 | Ocrevus Zunovo | $26 |
| TG Therapeutics | Meals · 2025-09-02 | Briumvi | $31 |
| Lundbeck | Meals · 2025-08-20 | Vyepti | $19 |
| ANI Pharmaceuticals | Meals · 2025-08-11 | Purified Cortrophin Gel | $27 |
| Alexion Pharmaceuticals | Meals · 2025-07-15 | Ultomiris | $14 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Kesimpta | $30 |
| Alexion Pharmaceuticals | Meals · 2025-06-25 | Ultomiris | $32 |
| Alexion Pharmaceuticals | Meals · 2025-06-20 | Ultomiris | $32 |
| Abbvie | Meals · 2025-06-06 | Botox | $31 |
| Novartis Pharmaceuticals | Meals · 2025-04-23 | Kesimpta | $32 |
| Catalyst Pharmaceuticals | Meals · 2025-03-24 | Fycompa | $36 |
| Eisai | Meals · 2025-02-13 | Leqembi | $23 |
| Neurelis | Meals · 2025-02-12 | Valtoco | $43 |
| Catalyst Pharmaceuticals | Meals · 2025-02-10 | Fycompa | $24 |
| Catalyst Pharmaceuticals | Meals · 2025-02-03 | Fycompa | $15 |
| Lilly USA | Meals · 2025-01-23 | Kisunla | $24 |
| Neurelis | Meals · 2025-01-21 | Valtoco | $36 |
| Genentech USA | Meals · 2025-01-15 | Ocrevus | $26 |
| Lundbeck | Meals · 2025-01-15 | Vyepti | $27 |
| ANI Pharmaceuticals | Meals · 2025-01-08 | Purified Cortrophin Gel | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $766
| Catalyst Pharmaceuticals | Fycompa | $176 | 8 payments
|
| Abbvie | Botox | $139 | 6 payments
|
| Neurelis | Valtoco | $105 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $90 | 3 payments
|
| Ucb | Briviact | $72 | 3 payments
|
| Banner Life Sciences | Bafiertam | $42 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $31 | 1 payment
|
| Kyowa Kirin | Nourianz | $26 | 1 payment
|
| Lundbeck | Vyepti | $25 | 1 payment
|
| Sumitomo Pharma America | Aptiom | $23 | 1 payment
|
| Lilly USA | Amyvid | $18 | 1 payment
|
| EMD Serono | None | $18 | 1 payment
|
2023: $581
| Lundbeck | Vyepti | $85 | 3 payments
|
| Catalyst Pharmaceuticals | Fycompa | $79 | 4 payments
|
| Acorda Therapeutics | Inbrija | $61 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $59 | 2 payments
|
| AbbVie | Botox | $53 | 2 payments
|
| Lilly USA | Amyvid | $44 | 3 payments
|
| Genentech USA | Enspryng | $32 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $30 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $29 | 1 payment
|
| Otsuka America Pharmaceutical | Nuedexta | $21 | 1 payment
|
| Horizon Therapeutics plc | Uplizna | $16 | 1 payment
|
| Scilex Pharmaceuticals | Elyxyb | $16 | 1 payment
|
| Janssen Pharmaceuticals | Ponvory | $16 | 1 payment
|
| Eisai | Fycompa | $15 | 1 payment
|
| Genzyme | Aubagio | $14 | 1 payment
|
| Kyowa Kirin | Nourianz | $13 | 1 payment
|
2022: $168
| Abbvie | Duopa | $47 | 3 payments
|
| Biogen | Tysabri | $40 | 2 payments
|
| Genzyme | Aubagio | $38 | 2 payments
|
| Lilly USA | Emgality | $18 | 1 payment
|
| Sunovion Pharmaceuticals | Kynmobi | $13 | 1 payment
|
| Kyowa Kirin | Nourianz | $12 | 1 payment
|
2021: $492
| Teva Pharmaceuticals USA | Ajovy | $164 | 3 payments
|
| Alexion Pharmaceuticals | Soliris | $68 | 3 payments
|
| Lundbeck | Vyepti | $54 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $50 | 3 payments
|
| Banner Life Sciences | Bafiertam | $35 | 2 payments
|
| Eisai | Fycompa | $30 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $24 | 1 payment
|
| EMD Serono | None | $20 | 1 payment
|
| AbbVie | Qulipta | $16 | 1 payment
|
| Genzyme | Aubagio | $16 | 1 payment
|
| Adamas Pharmaceuticals | Gocovri | $15 | 1 payment
|
2020: $329
| Alexion Pharmaceuticals | Soliris | $117 | 5 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $41 | 2 payments
|
| EMD Serono | Mavenclad | $35 | 2 payments
|
| LivaNova USA | Vns Therapy | $28 | 1 payment
|
| Ucb | Neupro | $25 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $22 | 1 payment
|
| Eisai | Fycompa | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| US WorldMeds | Xadago | $19 | 1 payment
|
2019: $1,251
| Akcea Therapeutics | Tegsedi | $203 | 4 payments
|
| EMD Serono | Mavenclad | $139 | 9 payments
|
| Alexion Pharmaceuticals | Soliris | $103 | 5 payments
|
| Medtronic Vascular | Reveal Linq | $98 | 1 payment
|
| Eisai | Fycompa | $91 | 5 payments
|
| Biogen | Tysabri | $90 | 4 payments
|
| CSL Behring | Hizentra | $62 | 3 payments
|
| Ucb | Neupro | $51 | 2 payments
|
| Merz North America | Xeomin | $51 | 2 payments
|
| Genzyme | Pompe - Disease | $43 | 2 payments
|
| Supernus Pharmaceuticals | Oxtellar Xr | $36 | 2 payments
|
| Sunovion Pharmaceuticals | Aptiom | $33 | 3 payments
|
| US WorldMeds | Xadago | $33 | 2 payments
|
| Portola Pharmaceuticals | Andexxa | $32 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $29 | 1 payment
|
| Amgen | Aimovig | $29 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $24 | 1 payment
|
| Pfizer | Lyrica | $21 | 1 payment
|
| AbbVie | Duopa | $18 | 1 payment
|
| Vertical Pharmaceuticals | Osmolex Er | $18 | 1 payment
|
| Chiesi USA | Cleviprex | $17 | 1 payment
|
| Lundbeck | Northera | $16 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $15 | 1 payment
|
Professional record
- NPI
- 1144288713
- Licence
- CA A34987California A34987: Current · expires 2027-08-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- 2577 Samaritan Dr, Suite #840, San Jose, CA, 95124
- NPI first listed
- 2006-05-03
- NPI last updated
- 2014-08-21
This is when the NPI record was last certified, not a medical board exam.